Your Location is set to:

ALLIANCE A0114 (DFCI 16-727)


To enroll participants who have been treated for node-positive, HER2 negative breast cancer. Participants will be asked to take aspirin or a placebo (looks like the aspirin but contains no medication) to see if the aspirin can decrease breast cancer recurrence. 

Principal Investigator(s)
Jennifer Crook, MD

Clinical Trial Categories

  • Outpatient Medications
  • Breast Cancer
Rebecca Buscanera, RNC, BSN at 508-862-5799
How to Participate

Speak to your oncologist at the Cape Cod Healthcare Regional Cancer Center or contact our research nurse Rebecca Buscanera, RN at 508-862-5799.